Drug Topics

JUNE 26, 2025

Pharmacy technicians must be recognized and empowered as essential, long-term professionals to improve workplace well-being, patient care, and pharmacy success.

Patient Care 502

Patient Care 502

PhRMA

JUNE 26, 2025

As the debate over drug pricing intensifies, some proposals—like the Most Favored Nation model—may sound appealing in theory, but they carry serious unintended consequences.

157

157

Drug Topics

JUNE 26, 2025

Nathan Ramsbacher, PharmD, emphasizes that one of the most significant barriers to clinical quality is patients' inability to access crucial medications due to cost.

394

394

STAT

JUNE 26, 2025

A federal vaccine advisory panel, which health secretary Robert F. Kennedy Jr. recently stacked with handpicked members , recommended on Thursday that Americans should not receive flu vaccines containing the preservative thimerosal. The votes — there were three related to the topic — reflected new members’ concerns about safety issues tied to the preservative, despite numerous studies conducted over the past quarter-century that have found no such issues.

Vaccines 143

Vaccines 143

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JUNE 26, 2025

With the emergence of increased GLP-1 use and alternative PBM models, Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, joined Drug Topics to discuss current trends in drug benefit design.

247

247

PharmaVoice

JUNE 26, 2025

Proposed cuts to public funding for early science have led to an outcry in scientific circles. For biopharma leaders, the effects are still up in the air.

147

147

STAT

JUNE 26, 2025

Black and Hispanic people are “significantly less likely” to receive two medications used to treat opioid addiction, according to a new study.  Compared to white patients, Black and Hispanic patients were 17.1% and 16.2% less likely, respectively, to receive either buprenorphine or naltrexone within 180 days of a health care event related to their substance use, like a nonfatal overdose or addiction-related infection.

145

145

PharmaVoice

JUNE 26, 2025

New members of the ACIP panel raised questions about the evidence supporting COVID vaccines, and signaled plans to look at other established shots, like those for measles and hepatitis B.

Vaccines 130

Vaccines 130

Pharmafile

JUNE 26, 2025

Sanofi has announced that the US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to riliprubart for the treatment of antibody-mediated rejection (AMR) in solid organ transplantation. The designation recognises the significant unmet need for patients facing AMR – an immune response that can lead to organ damage and transplant failure.

FDA 86

FDA Immunization 86

Pharmacy Times

JUNE 26, 2025

SGLT2 inhibitors improve diabetes management but may cause erythrocytosis without increasing blood clot risks, highlighting the need for careful monitoring.

102

102

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JUNE 26, 2025

A committee that advises the Centers for Disease Control and Prevention on vaccines voted Thursday to recommend the use of a new monoclonal antibody against RSV in babies, Merck’s Enflonsia.  The monoclonal antibody, given to babies under 8 months of age entering their first RSV season, is the second product of this kind to enter the market, joining Sanofi and AstraZeneca’s Beyfortus in the RSV toolkit.

Vaccines 140

Vaccines 140

Fierce Healthcare

JUNE 26, 2025

Not long after the state of Louisiana sued CVS Health in three separate lawsuits, the company's PBM was told it must pay $95 million in a long-running suit.

93

93

Pharmaceutical Technology

JUNE 26, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Compounding 69

Compounding Communication Packaging Labelling 69

Pharmacy Times

JUNE 26, 2025

Amyvid is used for brain imaging to estimate amyloid plaque density in patients with cognitive impairment undergoing evaluation for Alzheimer disease.

Labelling 73

Labelling FDA 73

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

JUNE 26, 2025

State workers who for decades have been pivotal in identifying U.S. cancer trends, curbing new cases, and improving screening fear their federally funded programs could be deeply cut or eliminated altogether come July.  By next week, state and local programs that work on cancer are supposed to find out if their annual allocations from the Centers for Disease Control and Prevention will be renewed.

133

133

pharmaphorum

JUNE 26, 2025

Biogen is looking to the future of its spinal muscular atrophy (SMA) business, taking a candidate offering once-yearly dosing into phase 3

76

76

Pharmacy Times

JUNE 26, 2025

Explore how community pharmacies enhance care for diverse patients with disabilities, addressing barriers and improving accessibility in pharmacy services.

Community Pharmacies 65

Community Pharmacies 65

STAT

JUNE 26, 2025

Over the last five years, health systems, medical societies, and their clinicians have been working to unravel the role of race in clinical practice. After clinical algorithms that use race as a variable came under scrutiny in 2020, several commonly used tools have been revised to align with medicine’s understanding that race is not a biological construct, but a social one.

111

111

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JUNE 26, 2025

Explore the latest FDA-approved novel drugs transforming treatment options for various conditions, enhancing patient care and outcomes in community and specialty pharmacy.

Specialty Pharmacies 81

Specialty Pharmacies Patient Care FDA 81

Fierce Pharma

JUNE 26, 2025

Approved eight months ago for a certain class of patients with both hemophilia A or B, Pfizer’s Hympavzi has demonstrated its effectiveness in another group of patients with the bleeding disorder.

86

86

Pharmacy Times

JUNE 26, 2025

The Advisory Committee on Immunization Practices (ACIP) voted 5-1, with 1 voter abstaining, to recommend that adults receive seasonal influenza vaccines that do not contain the preservative thimerosal.

Vaccines 73

Vaccines Immunization 73

European Pharmaceutical Review

JUNE 26, 2025

EPR Issue 2 includes articles on the impact of tariffs on the pharmaceutical supply chain, advances in bioprocessing, the potential of digital twins in manufacturing, cell and gene therapies and more. Included in this issue of European Pharmaceutical Review : FOREWORD Setting rationale specifications for early-phase non-mutagenic impurities David Elder David P Elder Consultancy SUPPLY CHAIN Tariff risks and opportunities for pharma manufacturers Clifford Rossi, PhD, University of Maryland IN-D

52

52

Pharmacy Times

JUNE 26, 2025

A recent meta-analysis reveals low persistence rates with anti-dementia drugs, highlighting factors influencing adherence and the need for standardized reporting.

65

65

Hospital Pharmacy Europe

JUNE 26, 2025

As president of the International Society of Oncology Pharmacy Practitioners and co-chair of the UK SACT Board, Netty Cracknell is championing the role of oncology pharmacy in delivering high-quality cancer care worldwide and supporting progress, as Saša Janković explains. Halfway through her two-year tenure as president of the International Society of Oncology Pharmacy Practitioners (ISOPP), not to mention her role as co-chair of The UK Systemic Anti-Cancer Therapy (SACT) Board, Netty Cracknell

Patient Care 52

Patient Care Hospitals Documentation 52

Pharmacy Times

JUNE 26, 2025

Megan Ehret, PharmD, MS, BCPP, FAAPP, discusses the clinical benefits of long-acting injectables for treating alcohol use disorder and psychiatric conditions, highlighting the pharmacist’s role in improving adherence, addressing stigma, and expanding access to care.

65

65

Pharma Marketing Network

JUNE 26, 2025

Search engine optimization (SEO) has evolved into one of the most critical pillars of digital success, particularly for industries like pharmaceuticals where visibility, credibility, and patient trust are non-negotiable. SEO Campaigns in pharma marketing serve as essential mechanisms to drive targeted traffic, increase awareness, and position brands as authoritative resources.

FDA 52

FDA Communication 52

The Checkup by Singlecare

JUNE 26, 2025

Brain health refers to how well the brain functions, and it can affect so many parts of life, including cognition, emotions, movement, and sensation, according to the National Institute on Aging. As people age, certain parts of the brain can shrink, communication within the brain can diminish, blood flow in the brain can decrease, and inflammation may occur.

Community Pharmacies 52

Community Pharmacies Dosage Communication 52

Pharmafile

JUNE 26, 2025

CSL Behring has announced a key milestone for its hereditary angioedema (HAE) therapy, garadacimab, following a positive benefit assessment by Germany’s Institute for Quality and Efficiency in Health Care (IQWiG). The agency concluded there is a “hint of considerable additional benefit” for garadacimab compared to existing HAE prophylaxis therapies, based on robust indirect comparisons using […] The post CSL Behring’s therapy for hereditary angioedema receives positive assessment in German

59

59

pharmaphorum

JUNE 26, 2025

Skip to main content Thursday 26 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Oncology -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -W

Pharmaceutical Companies 83

Pharmaceutical Companies Pharmaceutical Companies FDA 83

STAT

JUNE 26, 2025

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. This week,  Best Buy ‘s home health subsidiary  Current Health  revealed  it was once again an independent company run by cofounder  Chris McGhee , who left the company in 2024.

Hospitals 94

Hospitals 94

Pharmafile

JUNE 26, 2025

Oxeltis, a French contract research organisation specialising in medicinal and organic chemistry, has announced that it will lead the BUNYANTIVIR project alongside prominent academic partners, having secured nearly €800,000 in funding from France’s National Research Agency and the Defense Innovation Agency. The three-year project aims to advance the preclinical development of a novel antiviral targeting […] The post Oxeltis secures €800,000 grant to advance antiviral candidate for emerging

52

52

European Pharmaceutical Review

JUNE 26, 2025

A new dual-targeting radiopharmaceutical cancer therapy has demonstrated its efficacy and safety in a first-in-human study. The targeted approach enabled enhanced precision and a more potent drug delivery to tumour cells. Nine patients with advanced adenocarcinomas received a single treatment cycle of the drug candidate 177 Lu-labeled FAPI-RGD. Preliminary data showed that the combination therapy facilitated tumour shrinkage or halted growth in 88.9 percent of patients.

Labelling 52

Labelling Hospitals 52

Pharmaceutical Technology

JUNE 26, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Packaging 52

Packaging Communication Hospitals Insurance 52